Using a Spearman rank correlation, we found a significant correlation whereby a reduction of CD3 + (p = 0.04, rho = 0.60) and CD4 + (p = 0.01, rho = 0.72) T-cells was associated with decreased residual tumour content post-1 cycle of treatment. This evidence concerns the gene CD4 and neoplasm.